Table 2.
Clinical information (n = 26; IVIG intravenous immunoglobulins, CIDP chronic inflammatory demyelinating polyneuropathy, INCAT Inflammatory Neuropathy Cause and Treatment, GS glucocorticosteroids)
| typical | atypical | p-values atypical vs. typical | ||
|---|---|---|---|---|
| Sex | male | 3/9 (33%) | 14/17 (82%) | 0.013 |
| female | 6/9 (66%) | 3/17 (18%) | ||
| Age (years) | mean | 61.0 | 57.2 | 0.512 |
| range | 32-78 | 33-74 | ||
| Previous treatment | None | 3/9 (33%) | 9/17 (53%) | 0.429a |
| IVIG | 4/9 (44%) | 6/17 (35%) | 0.652a | |
| Steroid | 2/9 (22%) | 2/17 (12%) | 0.547a | |
| Time since diagnosis | mean | 4.1 | 4.2 | 0.860 |
| (years) | range | 1-8 | 1-7 | |
| INCAT | mean | 3.2 | 2.3 | 0.045 |
| Range | <1-8 | <1-7 | ||
| Disease activity | range | 1-5 | 1-3 | |
| active-unstable | 6/9 (66%) | 14/17 (82%) | 1.000b | |
| active-stable | 1/9 (11%) | 0/17 (0%) | 0.333b | |
| in remission | 2/9 (22%) | 3/17 (18%) | 1.000b | |
| Therapy response | responder | 9/9 (100%) | 8/17 (47%) | 0.022 |
| non-responder | 0/9 (0%) | 9/17 (53%) |
Fishers exact test for sex, previous treatment, disease activity and therapy response
acompared versus treatment naïve patients
bcompared versus remission state; unpaired t-test for age and INCAT score; Mann-Whitney test for time since diagnosis